Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hertzberg

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Internal Medicine Journal|February 18, 2009
Single versus double unrelated umbilical cord blood units for allogeneic transplantation in adults with advanced haematological malignancies: a retrospective comparison of outcomesK Bradstock, M Hertzberg, I Kerridge, et al.
Bone Marrow Transplantation|March 4, 2014
Outcomes following second allogeneic haematopoietic transplants using fludarabine-melphalan conditioningI Bilmon, I Nivison-Smith, M Hertzberg, et al.
Internal Medicine Journal|June 1, 2012
Haploidentical bone marrow transplants for haematological malignancies using non-myeloablative conditioning therapy and post-transplant immunosuppression with cyclophosphamide: results from a single Australian centreI A Bilmon, J Kwan, D Gottlieb, et al.
Annals of the New York Academy of Sciences|June 27, 1983
Hormonal regulation of fibrinogen synthesis in cultured hepatocytesG Grieninger, P W Plant, T J Liang, et al.
Bone Marrow Transplantation|June 20, 2017
An individualised risk-adapted protocol of pre- and post transplant zoledronic acid reduces bone loss after allogeneic stem cell transplantation: results of a phase II prospective trialA Grigg, B Butcher, B Khodr, et al.
Bone Marrow Transplantation|November 10, 2009
Reduced-intensity conditioned allogeneic haematopoietic stem cell transplantation results in durable disease-free and overall survival in patients with poor prognosis myeloid and lymphoid malignancies: eighty-month follow-upS Patil, A Spencer, A Schwarer, et al.
Leukemia & Lymphoma|July 16, 2005
Autografting followed by rituximab for chemosensitive mantle cell lymphoma: a pilot study and literature reviewA P Grigg, J Bashford, J F Seymour, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 29, 2001
A transcriptional roadmap to wood formationM Hertzberg, H Aspeborg, J Schrader, et al.
Australian Dental Journal|June 8, 2018
Oral health and dental morbidity in long-term allogeneic blood and marrow transplant survivors in AustraliaG Dyer, L Brice, M Schifter, et al.
Psychological Medicine|January 1, 1997
Assessment of a new self-rating scale for post-traumatic stress disorderJ R Davidson, S W Book, J T Colket, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Internal Medicine Journal|February 18, 2009
Single versus double unrelated umbilical cord blood units for allogeneic transplantation in adults with advanced haematological malignancies: a retrospective comparison of outcomesK Bradstock, M Hertzberg, I Kerridge, et al.
Bone Marrow Transplantation|March 4, 2014
Outcomes following second allogeneic haematopoietic transplants using fludarabine-melphalan conditioningI Bilmon, I Nivison-Smith, M Hertzberg, et al.
Internal Medicine Journal|June 1, 2012
Haploidentical bone marrow transplants for haematological malignancies using non-myeloablative conditioning therapy and post-transplant immunosuppression with cyclophosphamide: results from a single Australian centreI A Bilmon, J Kwan, D Gottlieb, et al.
Annals of the New York Academy of Sciences|June 27, 1983
Hormonal regulation of fibrinogen synthesis in cultured hepatocytesG Grieninger, P W Plant, T J Liang, et al.
Bone Marrow Transplantation|June 20, 2017
An individualised risk-adapted protocol of pre- and post transplant zoledronic acid reduces bone loss after allogeneic stem cell transplantation: results of a phase II prospective trialA Grigg, B Butcher, B Khodr, et al.
Bone Marrow Transplantation|November 10, 2009
Reduced-intensity conditioned allogeneic haematopoietic stem cell transplantation results in durable disease-free and overall survival in patients with poor prognosis myeloid and lymphoid malignancies: eighty-month follow-upS Patil, A Spencer, A Schwarer, et al.
Leukemia & Lymphoma|July 16, 2005
Autografting followed by rituximab for chemosensitive mantle cell lymphoma: a pilot study and literature reviewA P Grigg, J Bashford, J F Seymour, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 29, 2001
A transcriptional roadmap to wood formationM Hertzberg, H Aspeborg, J Schrader, et al.
Australian Dental Journal|June 8, 2018
Oral health and dental morbidity in long-term allogeneic blood and marrow transplant survivors in AustraliaG Dyer, L Brice, M Schifter, et al.
Psychological Medicine|January 1, 1997
Assessment of a new self-rating scale for post-traumatic stress disorderJ R Davidson, S W Book, J T Colket, et al.
Pageof 6